I-Nuvigil (armodafinil) ivela ku-Provigil (modafinil), okuyinto abanye abantu abane-MS bathatha ukulwa nokukhathala okuhlobene ne-MS .
Sibutsetelo se-Nuvigil
I-Nuvigil isetshenziselwa ukuthuthukisa ukuvuka kwabadala ngokulala ngokweqile okuhlobene nezimo zempilo ezintathu ezilandelayo:
- i-obnetive obstructive sleep apnea
- i-narcolepsy
- shift function disorder
Lokhu kuthiwa, ngezinye izikhathi kusetshenzisiwe ngaphandle kwelebuli (okusho ukuthi akuyona i-FDA evunyelwe) ukuphatha ukukhathala kubantu abane-MS.
I-Nuvigil ayiyona inguqulo yesizukulwane ka-Provigil kodwa ivela ku-Provigil (isithunzi sokunene, ukuba yiyona ngqo). Ukusebenzisa ingxenye nje ye-molecule eyenza i-Provigil kucatshangwa ukuthi iyindlela yokuthola izinzuzo eziningi ngemiphumela emibi embalwa, okubonakala ibhekene nesondlo sokunxele.
Lokhu kuthiwa, uN Nuvigil angabangela nezinhlobo ezifanayo zemiphumela emibi njenge-Provigil, isisindo esibi kakhulu sokushukela isikhumba noma ukusabela okungathí sina. Eqinisweni, uma umuntu eveza noma yiziphi izibonakaliso zokuphazamiseka noma ukusabela okweqile, kubalulekile ukuthi bafune usizo oluphuthumayo ngokushesha. Ezinye zalezi zimpawu zihlanganisa:
- ukuqhuma kwesikhumba, ukuvuthwa, ukugcoba kanye / noma ukuhlunga isikhumba, izilonda emlonyeni
- ukuvuvukala kobuso, amehlo, izindebe, ulimi, noma umphimbo
- izinkinga zokugwinya noma ukuphefumula
- umkhuhlane
- ukuvuvukala kwemilenze
- ukuphuka kwamehlo kanye / noma umchamo omnyama
Eminye imiphumela engaba yingozi kakhulu kubandakanya izimpawu zengqondo ezinjengokuzizwa ecindezelekile, ukukhathazeka, ukubhekana nezinkinga, ukuziphatha, noma ukuziphatha okubi, kanye / noma ukucabanga okuzibulala.
Izinkinga zenhliziyo nazo zingase zenzeke futhi ziqinisekise ukunakekelwa kwezempilo ngokushesha. Izimpawu ezinokwenzeka zihlanganisa ubuhlungu besifuba, ukuphefumula kwezinkinga, noma ukushaya kwenhliziyo engavamile.
Ngaphandle kwale mibi emibi kakhulu, i-Nuvigil ivame ukudala le mibi emibi kubantu:
- ikhanda
- isiyaluyalu
- isiyezi
- izinkinga zokulala
Kubalulekile ukuxhumana nodokotela wakho uma uhlangabezana nanoma yimiphi imiphumela emibi eqhubekayo noma ehluphayo, kuhlanganise nalabo abangenhla noma okunye okungeziwe.
Futhi, uNuvigil angase ahlanganyele futhi / noma anciphise ukusebenza kwemithi ethile efana nezindlela zokulawula ukubeletha kwama-hormones (amaphilisi, isibhamu, izimpande, ama-patches, izindandatho, nama-IUD). Lokhu kusho ukuthi owesifazane angase abe nethuba lokukhulelwa ngenkathi ethatha uNuvigil nenyanga eyodwa ngemuva kokumisa uNuvigil.
Ngenxa yokuthi uNobvil uyakwazi ukusebenzisana neminye imithi, qiniseka ukuthi utshela udokotela wakho zonke izinkinga zakho zezokwelapha nayo yonke imithi oyithathayo kuhlanganise nemiyalelo, ama-herbals, ama-supplements, amavithamini, kanye nemithi eminingi.
Amanye amaphuzu amaningana athwala ukukhuluma. Izinga lakho le-Nuvigil lizohluka kunezindlela zakho ze-Provigil, ngakho qaphela lapha bese uyithatha kuphela njengoba ufundiswe udokotela wakho. Futhi, umshuwalense wakho awukwazi ukumboza i-Nuvigil ezingeni elifanayo njengoba limbozwe i-Provigil-kungase kube yimithi ebiza kakhulu kwabanye.
Ingabe I-Nuvigil Isebenza?
Ubufakazi besayense obusekela ukusetshenziswa kukaN Nuvigil ekuphatheni kahle ukukhathala ku-MS bubuthakathaka futhi abukali ngalesi sikhathi. Lokhu kuthiwa, kungase kusebenze kwabanye abantu, ngakho udokotela wakho angancoma ukuthi uzame, ikakhulukazi uma ezinye izindlela zokwelashwa zingasebenzi. Ekukhatheni ukukhathala, kuvame ukuhlanganiswa okuyinkimbinkimbi kokungenelela okusebenzayo kufaka phakathi ukuzivocavoca, ukulala kahle, ukubhekana nezinye izindaba zezempilo ezingase zibe nomthelela ekukhathala, kanye nemithi
Izwi elivela
Nakuba i-Nuvigil ingabangela imiphumela emibi njengezinkinga zenhliziyo noma yengqondo, ngokuvamile ibekezeleleke kahle futhi ingaba yindlela enengqondo kwabanye abantu abanokukhathala okuhlobene ne-MS.
> Imithombo:
> Asano M, i-Finlayson ML. Ukuhlaziywa kwe-meta ngezinhlobo ezintathu ezihlukene zokuphathwa kokukhathala kubantu abano-multiple sclerosis: ukuzivocavoca, imfundo, kanye nemithi. I-Mult Scler Int. 2014; 2014: 798285.
> Braley TJ, uChervin RD. Ukhathala ku-multiple sclerosis: Izindlela, ukuhlola, kanye nokwelapha. Ukulala . 2010 Aug 1; 33 (8): 1061-67.
> Bruce J, Hancock L, Roberg B, Brown A, Henkelman E, Lynch S. Impact ye-armodafinil ekuqondeni kwe-multiple sclerosis: isifundo sezindiza esingenakulinganiswa, esiphambanisekile. I-Cogn Behav Neurol . 2012 Sep; 25 (3): 107-14.
> Umhlahlandlela Wokuthola Imithi (April 2015). I-Nuvigil.